Noveris Health Sciences is trading at CA$0.07, up +7.69%; broader biotech strength may be contributing, though a direct link is unconfirmed.
- The company’s release page has no announcement dated October 15 or 16; its latest release is dated September 9.
- The supplied sector context reports the XBI up 2.20%, supported by positive clinical and regulatory news elsewhere in the sector.